State of the art and perspectives of CAR-T cell therapy for neuroblastoma
Cytotherapy, 2024 - Elsevier
Neuroblastoma is a solid, neuroendocrine pediatric solid tumor with divergent clinical
behavior. Patients with high-risk disease have poor prognosis despite complex multimodal …
behavior. Patients with high-risk disease have poor prognosis despite complex multimodal …
State of the art and perspectives of chimeric antigen receptor T cells cell therapy for neuroblastoma.
D Lutskovich, A Meleshko, M Katsin - Cytotherapy, 2024 - europepmc.org
Neuroblastoma (NB) is a solid, neuroendocrine pediatric solid tumor with divergent clinical
behavior. Patients with high-risk diseases have poor prognoses despite complex multimodal …
behavior. Patients with high-risk diseases have poor prognoses despite complex multimodal …
State of the art and perspectives of chimeric antigen receptor T cells cell therapy for neuroblastoma
D Lutskovich, A Meleshko, M Katsin - Cytotherapy - pubmed.ncbi.nlm.nih.gov
Neuroblastoma (NB) is a solid, neuroendocrine pediatric solid tumor with divergent clinical
behavior. Patients with high-risk diseases have poor prognoses despite complex multimodal …
behavior. Patients with high-risk diseases have poor prognoses despite complex multimodal …